Document:

BIOS-EX10.1-2013.03.31

EXHIBIT 10.1

WAIVER OF NOTICE PROVISION

This Waiver of Notice Provision (this “Waiver”) is made this 8th day of March, 2013 by and between BioScrip, Inc., a Delaware corporation (the “Company”), and Kohlberg Investors V, L.P., a Delaware limited partnership (“Kohlberg”).

RECITALS

The following recitals are a material part of this Waiver:

A.    Reference is made to that certain stockholders’ agreement dated as of January 24, 2010 (the “Agreement”), by and among Kohlberg, Kohlberg Partners V, L.P., a Delaware limited partnership, Kohlberg Offshore Investors V, L.P., a Delaware limited partnership, Kohlberg TE Investors V, L.P., a Delaware limited partnership, KOCO Investors V, L.P., a Delaware limited partnership, Robert Cucuel, Mary Jane Graves, Nitin Patel, Joey Ryan, Colleen Lederer, Blackstone Mezzanine Partners II L.P., a Delaware limited partnership, Blackstone Mezzanine Holdings II L.P., a Delaware limited partnership, and S.A.C. Domestic Capital Funding, Ltd., a Cayman Islands limited company (collectively, the “Stockholders”) and the Company.

B.    Pursuant to Section 4.2 of the Agreement (“Section 4.2”), if the Company proposes to register any shares under the Securities Act of 1933, as amended (the “Act”), on any form (other than Form S-4 or Form S-8) that would legally permit the inclusion of the aggregate issued and outstanding shares of the Company’s Common Stock beneficially owned by the Stockholders, including such shares issuable upon the exercise of warrants (the “Stockholder Shares”), the Company shall give each of the Stockholders written notice thereof as soon as practicable but in no event fewer than 30 days prior to such registration, and shall include in such registration all Stockholder Shares requested in writing to be included therein, subject to the limitations set forth in Section 4.2. 
C.    The Company now contemplates filing a registration statement on Form S-3 (the “Registration Statement”), pursuant to the Act, for the delayed primary offering of its common and preferred stock, certain of its debt securities, warrants and units, and such Form S-3 legally permits the inclusion of the Stockholder Shares in accordance with Section 4.2.

D.    The Company desires to file the Registration Statement within the 30-day advance notice period required under Section 4.2.

E.    Section 7.8 of the Agreement (“Section 7.8”) provides that any term therein may be amended or waived by a written instrument signed by the Company, on one hand, and Stockholders holding not less than a majority of the Stockholder Shares, on the other hand.

F.    Kohlberg holds at least a majority of the Stockholder Shares.  

NOW THEREFORE, in consideration of the mutual covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Kohlberg hereby agree as follows:

1.    Recitals; Acknowledgments.  The Recitals set forth above are true and accurate, are a material part of this Waiver, are hereby incorporated by reference, and the parties are entitled to rely thereon.

2.    Waiver of Notice. Kohlberg hereby expressly and forever waives, on behalf of all of the Stockholders in accordance with Section 7.8, the Stockholders’ rights to a 30-day advance notice of Company registration, pursuant to Section 4.2, in connection with the Company’s contemplated filing of the Registration Statement.  Kohlberg acknowledges time is of the essence in respect of the Company’s filing of the Registration Statement and thus, the 30-day advance notice to Stockholders pursuant to Section 4.2 is not necessary.  

3.    Amendment. Section 4.2 is hereby replaced in its entirety with the following:

“4.2 Company Registration. In the event that the Company proposes to register any shares under the Securities Act in connection with a public offering (other than a Demand Registration) on any form (other than Form S-4 or Form S-8) that would legally permit the inclusion of Stockholder Shares, the Company shall give each of the Stockholders prompt written notice, which notice shall describe the offering contemplated thereby, of the Company’s intention to effect such a registration and will include in such registration all Stockholder Shares with respect to which the Company has received written requests for inclusion within seven (7) days after the delivery of the Company’s notice.  If in connection with such proposed registration the managing underwriter for such offering advises the Company that the number of Stockholder Shares requested to be included therein exceeds the number of shares that can be sold in such offering without adversely affecting the marketability thereof, any shares to be sold by the Company in such offering (“Company Shares”) shall have priority over any Stockholder Shares, and the number of Stockholder Shares to be included by a Stockholder in such registration shall be reduced pro rata on the basis of the number of Stockholder Shares held by such Stockholder and all other holders (other than the Company) exercising similar registration rights; provided that no other shares, other than the Company Shares to be sold in such offering, shall have priority over the Stockholder Shares.” 

4.    Entire Agreement; Mode Of  Modification. This Waiver and the documents referred to or contemplated herein constitute the sole and entire agreement between the parties with respect to the subject matter hereof and there are no other covenants, promises, agreements or understandings regarding the same.  This Waiver, including the provisions of this Section, may not be modified except by written amendment to this Waiver signed by the parties affected by the same, and the parties hereby: a) expressly agree that it shall not be reasonable for any of them to rely on any alleged, non-written amendment to this Waiver; b) irrevocably waive any and all right to enforce any alleged, non-written amendment to this Waiver; and c) expressly agree that it shall be beyond the scope of authority (apparent or otherwise) for any of their respective agents to agree to any non-written modification of this Waiver.

5.    Counterparts.  This Waiver may be executed in two or more counterparts, each of which shall be deemed an original and shall be binding upon any party executing the same and all of which together shall constitute one and the same document.  This Waiver shall become effective when all parties hereto have executed a counterpart hereof.

[Signature page follows]

BIOSCRIP, INC.

By:  /s/ Kimberlee Seah
Name: Kimberlee Seah
		
	Title:
	Senior Vice President and General Counsel

KOHLBERG INVESTORS V, L.P.

By: Kohlberg Management V, L.L.C., its general partner

By:   /s/ Gordon Woodward
Name:    Gordon Woodward
Title:     Authorized ManagerBIOS-EX10.2-2013.03.31

EXHIBIT 10.2

AMENDMENT NO. 2 TO STOCKHOLDERS’ AGREEMENT

This AMENDMENT NO. 2 (this “Amendment”) is made as of March 14, 2013 by and between BioScrip, Inc., a Delaware corporation (the “Company”), and Kohlberg Investors V, L.P., a Delaware limited partnership (“Kohlberg”).

RECITALS

The following recitals are a material part of this Amendment:

A.    Reference is made to that certain stockholders’ agreement dated as of January 24, 2010, by and among Kohlberg, Kohlberg Partners V, L.P., a Delaware limited partnership, Kohlberg Offshore Investors V, L.P., a Delaware limited partnership, Kohlberg TE Investors V, L.P., a Delaware limited partnership, KOCO Investors V, L.P., a Delaware limited partnership, Robert Cucuel, Mary Jane Graves, Nitin Patel, Joey Ryan, Colleen Lederer, Blackstone Mezzanine Partners II L.P., a Delaware limited partnership, Blackstone Mezzanine Holdings II L.P., a Delaware limited partnership, and S.A.C. Domestic Capital Funding, Ltd., a Cayman Islands limited company (collectively, the “Stockholders”) and the Company, as amended on March 8, 2013 by and between Kohlberg and the Company (the “Agreement”).  Capitalized terms used herein and not otherwise defined herein shall have the respective meanings given to them in the Agreement.

B.    Kohlberg and the Company desire to further amend the Agreement as provided herein. 
C.    Section 7.8 of the Agreement provides that any term therein may be amended or waived by a written instrument signed by the Company, on one hand, and Stockholders holding not less than a majority of the Stockholder Shares, on the other hand.

D.    Kohlberg holds at least a majority of the Stockholder Shares.  

NOW THEREFORE, in consideration of the mutual covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Kohlberg and the Company hereby agree as follows:

1.    Recitals; Acknowledgments.  The Recitals set forth above are true and accurate, are a material part of this Amendment, are hereby incorporated by reference, and the parties are entitled to rely thereon.

2.    Amendment. Section 4.6 of the Agreement is hereby replaced in its entirety with the following:

“4.6 Limitations.  The Company shall not be obligated to effect a Demand Registration for a period of three months following the effective date of a registration statement filed in connection with any registration effected under Section 4.1 or 4.2.  Notwithstanding anything to the contrary in the Escrow Agreement, as defined in the Merger Agreement (the “Escrow Agreement”), the provisions of Section 4 of this Agreement shall apply to all of the Stockholder Shares that are subject to the Escrow Agreement (the “Escrow Shares”); provided that (A) the Company shall have no obligations whatsoever under Section 4 of this Agreement in respect of any Escrow Shares that have been paid to the Company in accordance with Section 2(b) or Section 3 of the Escrow Agreement, and (B) any Escrow Shares so paid to the Company that have previously been registered under the Securities Act in connection with a public offering may be de-registered by the Company by means of post-effective amendment under the Securities Act.  The Company shall have no obligation to file a prospectus supplement under the Securities Act in respect of any Escrow Shares for which all conditions of release to the applicable Stockholder have not been satisfied under the Escrow Agreement.”

3.    Entire Agreement; Mode Of  Modification.  Except as expressly modified by this Amendment, all other terms of the Agreement shall remain in full force and effect.  This Amendment, together with the Agreement, as previously amended, constitutes the entire agreement between the parties with respect to the subject matter hereof.  This Amendment may be amended only by written amendment to this Amendment signed by the parties affected by the same. 

4.    Counterparts.  This Amendment may be executed in two or more counterparts, each of which shall be deemed an original and shall be binding upon any party executing the same and all of which together shall constitute one and the same document.  This Amendment shall become effective when all parties hereto have executed a counterpart hereof.

[Signature page follows]

BIOSCRIP, INC.

By:  /s/ Kimberlee C. Seah
Name: Kimberlee C. Seah
		
	Title:
	Senior Vice President, Secretary and General Counsel

KOHLBERG INVESTORS V, L.P.

By: Kohlberg Management V, L.L.C., its general partner

By:   /s/ Gordon Woodward
Name:    Gordon Woodward
Title:     Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00217-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00217-of-00352.parquet"}]]